WE GLADLY ACCEPT EMBLEM HEALTH CUSTOMER PRESCRIPTIONS PLEASE DISREGARD ANY NOTICES IMPLYING OTHERWISE
COVID-19 Linked to Increased Risk of Guillain-Barré Syndrome, a Rare but Serious Autoimmune Disorder, New Study Finds
In a new study, participants recently infected with COVID-19 were six times more likely to develop Guillain-Barré syndrome, where the immune system attacks the nerves.
Health News is provided as a service to J Drugs II site users by HealthDay. J Drugs II nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2023 HealthDay All Rights Reserved.